- Home
- / Ryvu Therapeutics
Ryvu Therapeutics
Stock Price
ZŁ48.3
2024-10-29
Market Capitalization
ZŁ1.2 B
2024-10-29
Revenue
ZŁ62.3 M
FY, 2025
Ryvu Therapeutics Summary
Company Summary
- Overview
- Ryvu Therapeutics is a biopharmaceutical company that develops drugs or treatments in oncology.
- Type
- Public
- Status
- Active
- Founded
- 2007
- HQ
- Kraków, PL | view all locations
- Website
- https://ryvu.com
- Cybersecurity rating
Table of Contents
Key People
Krzysztof Brzozka, Chief Scientific Officer
Kamil Sitarz, Chief Operating Officer
Vatnak Vat-Ho, Chief Business Officer
LocationsView all
2 locations detected
Kraków, Małopolskie HQ
Poland
Leona Henryka Sternbacha 2
Kraków, Małopolskie
Poland
Bobrzyńskiego 14
Ryvu Therapeutics Financials
Summary Financials
- Revenue (FY, 2025)
- zł62.3M
- Gross profit (FY, 2025)
- (zł25.6M)
- Net income (FY, 2025)
- (zł101.2M)
- Cash (FY, 2025)
- zł59.6M
- EBIT (FY, 2025)
- (zł94.4M)
- Enterprise value
- $1.2B